选择性Smurf1 E3酶抑制剂,可以防止转化
bioRxiv : the preprint server for biology
|October 24, 2023
概括
Smurf1 E3结合酶是骨质疏松症的药物标之一. 新的抑制剂通过阻止关键反应来选择性地阻断Smurf1活性,为骨密度下降提供了潜在的治疗方法.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- Smurf1 (SMAD无处不在调节因子1) 是一个HECT E3联酶,因患者的遗传微重复而与骨质疏松症有关.
- Smurf1淘汰赛小鼠的骨密度增加,突出显示Smurf1是骨质疏松症的可行的治疗标.
结论:
- 开发了高度选择性的Smurf1抑制剂,对骨质疏松症有潜在的治疗应用.
- 抑制剂的作用是通过在转基因分离阶段破坏E3酶催化机制来起作用.
- 需要进一步的研究来探索Smurf1抑制剂选择性的结构基础.
相关概念视频
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K


